Туберкульоз. Адаптована клінічна настанова, заснована на доказах (стр. 109 )

148. Medical Research Council Working Party on tuberculosis of the spine. A controlled trial of anterior spinal fusion and debridement in the surgical management of tuberculosis of the spine in patients on standard chemotherapy: a study in two centres in South Africa. Tubercle 1978;59(2):79-105.

149. Medical Research Council Working Party on Tuberculosis of the Spine. Five-year assessments of controlled trials of ambulatory treatment, debridement and anterior spinal fusion in the management of tuberculosis of the spine: studies in Bulawayo (Rhodesia) and in Hong Kong. Journal of Bone & Joint Surgery British Volume 1978;60B(2):163-177,

150. Medical Research Council Working Party on Tuberculosis of the Spine. A controlled trial of anterior spinal fusion and debridement in the surgical management of tuberculosis of the spine in patients on standard chemotherapy: a study in two centres in South Africa. Tubercle 1978;59(2):79-105.

151. Griffiths DL, Seddon H, Ball J, Darbyshire J et al. A controlled trial of short-course regimens of chemotherapy in patients receiving ambulatory treatment or undergoing radical surgery for tuberculosis of the spine. Indian Journal of Tuberculosis 1989;36(2 SUPPL.).

152. Strang JI, Kakaza HH, Gibson DG, Girling DJ et al. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei, Lancet 1987;2(8573);1418-1422.

153. Strang JIG, Karaza HHS, Gibson DG, Allen BW et al Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988;2(86H):759-764.

154. Mayosi BM, Ntsekhe M, Volmink ]A, Commerford P. Interventions for treating tuberculous pericarditis. The Cochrane Library 2002;(4).

155. Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ> Mayosi BM. Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. Monthly Journal of the Association of Physicians 2003;96(8):593-599,

156. Schrire V. Experience with pericarditis at Groote Schuur Hospital, Cape Town; an analysis of one hundred and sixty cases studied over a six-year period. South African Medical Journal 1959;33:810-817.

157. Hakim JG, Ternouth I, Mushangi E, Siziya S et al Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000;84(2): 183-188.

158. Strang JIG. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. Quarterly Journal of Medicine 2004;97(8):S25-535.

159. Anadol D, Kiper N, Gocmen A, Ozcelik U. Intermittent chemotherapy for miliary tuberculosis in children. Turkish Journal of Pediatrics 1999;41(l):53-59.

160. Ormerod LP, Green RM, Horsfield N. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000, International Journal of Tuberculosis & Lung Disease 2002;6(8):662-665,

161. Hayden SP, Springett VH. An assessment of the place of follow-up pulmonary tuberculosis. British Journal of Diseases of the Chest 1978;72(3):217-221.

162. Pearce SJ, Home NW. Follow-up of patients with pulmonary tuberculosis adequately treated by chemotherapy: is this really necessary? Lancet 1974;2{7881):fj41-643.

163. Bailey WC, Thompson DH, Jacobs S, Zisklnd M, Greenberg HB. Evaluating the need for periodic recall and re-examination of patients with inactive pulmonary tuberculosis. American Review of Respiratory Disease 1973;107(5):854-857.

164. Edsall J, Collins G. Routine follow-up of inactive tuberculosis, a practice to be abandoned. American Review of Respiratory Disease 1973;i07(5):850-853.

165. Pamra SP, Prasad G, Mathur GP. Relapse in pulmonary tuberculosis. American Review of Respiratory Disease 1976;113(I):67-72.

166. World Health Organization. Global tuberculosis control: surveilance, planning, financing. Switzerland: World Health Organization, 2004.

167. Bayer R, Stayton C, Desvarieux M, Healton C et al Directly observed therapy and treatment completion for tuberculosis in the United States; is universal supervised therapy necessary? American Journal of Public Health 1998[88(7):1052-1058.

168. Garner P. What makes DOT work? Directly observed therapy. Lancet 1998;352(9137):1326-1327.

169. Garner P, Volmink J. Directly observed therapy (letter). Lancet 1997;350(9078):666-667.

170. Chauik CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel, journal of the American Medical Association 1998;279(12):943-948.

171. Hill AR, Manikal VM, Riska PF. Effectiveness of directly observed therapy (DOT) for tuberculosis: a review of multinational experience reported in 1990-2000, Medicine 2002;81{3):179-193.

172. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. The Cochrane Library 2003;(1).

173. Maclntyre CR, Goebel K, Brown GV, Skull S et al A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting. International Journal of Tuberculosis & Lung Disease 2003;7{9) :848-854,

174. Matteelli A, Casalini C, Raviglione MC, El Hamad I et al. Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. American Journal of Respiratory & Critical Care M«fom<>2000;162(5):1653~1655.

175. Tandon M. DOTS versus self administered therapy (SAT) for patients of pulmonary tuberculosis: a randomised trial at a tertiary care hospital. Indian Journal of Medical Sciences 2002;56(1): 19-21,

176. Tulsky JP, Pilote L, Hahn JA, Zolopa A] et al Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Archives of Internal Medicine 2000; 160(5):697- 702,

177. Chauik P, Kazandjian VA, Comprehensive case management models for pulmonary tuberculosis. Disease Management & Health Outcomes 2003;11(9):571-577.

178. Kamolratanakul P. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Transactions of the Royal Society of Tropical Medicine & Hygiene 1999;93{5):552-557.

179. Walley JD, Khan MA, Newell JN, Khan MH. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001;357(9257):664-669.

180. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998;352(9137):1340-1343.

181. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. International Journal of Tuberculosis & Lung Disease 2000;4(6):550~554,

182. Malotte CK, Hollingshead JR, Larro M. Incentives vs outreach workers for latent tuberculosis treatment in drug users. American Journal of Preventive Medicine 2001;20(2): 103-107.

183. Chaisson RE, Barnes GL, Hackman J, Watkinson L et al. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. American Journal of Medicine 2001;110(8):610-615.

184. Wanciwalo E> Kapalata N, Egwaga S, Morkve O. Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Internationa! Journal of Tuberculosis & Lung Disease 2Q0i;S(l0yA248~l254.

185. Lwilla F, Schellenberg D, Masanja H, Acosta C et al Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in KiLombero district, Tanzania. Tropical Medicine & International Health 2003;8(3):204-210,

186. Wright J, Walley J, Philip A, Pushpananthan S et al Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Tropical Medicine & Inter national Health 2G04;9(5): 559-5 65,

187. Mullen pliance becomes concordance. British Medical Journal 1997;314(7092):691-692

188. Onnerod LP. Management of pulmonary and lymph node tuberculosis notified in 1998 in England and Wales. Clinical Medicine 2003;3(1):57~61.

189. Fox pliance of patients and physicians: experience and lessons from tuberculosis (1). British Medical journal 1983;287(6384):33~35.

190. Fox pliance of patients and physicians: experience and lessons from tuberculosis (II). British MerfJCflJ/owrnaJ1983;287(6385): 101-105.

191. Volmink J, Garner P. Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. British Medical Journal 1997:315(7120): 1403-1406.

192. Jin BW, Kim SC, Mori T, Shimao T. The impact of intensified supervisory activities on tuberculosis treatment, Tubercle & Lung Disease 1993;74(4):267-272,

193. Paramasivan R, Parfhasarathy RT, Rajasekaran S. Short course chemotherapy: a controlled study of indirect defaulter retrieval method. Indian Journal of Tuberculosis 1993;40:185-190.

194. Piiote L, Tulsky JP, Zolopa AR, Hahn JA et al. Tuberculosis prophylaxis in the homeless: a trial to improve adherence to referral. Archives of Internal Medicine 1996;156(2):161-165.

195. Salleras SL, Alcaide MJ, Altet GMN, Canela SJ et al. Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children: a randomized clinical trial. Tubercle & Lung Disease 1993;74(1):28-31.

196. Morisky DE, Malotte CK, Choi P et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Education Quarterly 1990;17(3):253-267.